What's new

Human medicines European public assessment report (EPAR): Fluenz, influenza vaccine (live attenuated, nasal), Date of authorisation: 03/06/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Fluenz, influenza vaccine (live attenuated, nasal), Date of authorisation: 03/06/2024, Revision: 3, Status: Authorised

Feb 28, 2025 - 10:31
 0
Human medicines European public assessment report (EPAR): Fluenz, influenza vaccine (live attenuated, nasal), Date of authorisation: 03/06/2024, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Fluenz, influenza vaccine (live attenuated, nasal), Date of authorisation: 03/06/2024, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

Opinion: STAT+: Why AI like Grok isn’t ready for the radiology big leagues

Next Article

InterContinental Indianapolis opens in the historic Illinois Building following ...

Related Posts

EMEA-003149-PIP01-21-M02

EMEA-003149-PIP01-21-M02

Mar 19, 2025  0

IRIS guide for applicants - How to create and submit sc...

Mar 12, 2025  0

Orphan designation: N-(2-Methoxyethyl)-6-methyl-N-[(3-methyl-2-thienyl)methyl]-2-oxo-1,2-dihydropyridine-4-carboxamide Treatment of glycogen storage disease type IV, 16/01/2025 Positive

Orphan designation: N-(2-Methoxyethyl)-6-methyl-N-[(3-m...

Feb 20, 2025  0